Traditionally, patients with obesity have been deemed ineligible for extracorporeal life
support (ELS) therapies such as extracorporeal membrane oxygenation (ECMO), given the …

Background There is a lack of large randomized controlled trials (RCTs) that
comprehensively evaluate the effects of venoarterial extracorporeal membrane oxygenation …

Background Several studies have shown that obesity is associated with better outcomes in
patients with cardiogenic shock (CS). Although this phenomenon, the “obesity paradox,” …

Abstract Background Triglyceride-glucose (TyG) index, a dependable indicator of insulin
resistance, has been identified as a valid marker regarding multiple cardiovascular …

Aims Given that fulminant myocarditis, characterized by unstable haemodynamics, is a
significant clinical challenge and that traditional pharmacological treatments have …

Aims Impella has become a new option for mechanical circulatory support in patients with
cardiogenic shock (CS); however, prognostic models for patients after Impella are lacking …

Background Obesity is known to impact outcomes of patients undergoing in-patient care in
general. The association between veno-arterial extracorporeal membrane oxygenation (VA …

Aims Cardiogenic shock (CS) is a life-threatening disease burdened by a mortality up to
50%. The epidemiology has changed with non-ischaemic aetiologies being predominant …

Metabolic support for patients on extra-corporeal membrane oxygenation Page 1 MCC 300412
CURRENT OPINION Metabolic support for patients on extra-corporeal membrane oxygenation …

Introduction Cardiogenic shock (CS) is associated with high mortality despite the
development of risk stratification tools and new treatment strategies. Obesity, although a risk …